BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6713092)

  • 1. Prognostic relevance of cellular morphology in multiple myeloma.
    Fritz E; Ludwig H; Kundi M
    Blood; 1984 May; 63(5):1072-9. PubMed ID: 6713092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple myeloma: relationship between survival and cellular morphology.
    Pasqualetti P; Casale R; Collacciani A; Abruzzo BP; Colantonio D
    Am J Hematol; 1990 Feb; 33(2):145-7. PubMed ID: 2301373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow histology in myeloma: its importance in diagnosis, prognosis, classification and staging.
    Bartl R; Frisch B; Burkhardt R; Fateh-Moghadam A; Mahl G; Gierster P; Sund M; Kettner G
    Br J Haematol; 1982 Jul; 51(3):361-75. PubMed ID: 7104223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of bone marrow histology in multiple myeloma.
    Subramanian R; Basu D; Dutta TK
    Indian J Cancer; 2009; 46(1):40-5. PubMed ID: 19282565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of plasma cell morphology in multiple myeloma.
    Carter A; Hocherman I; Linn S; Cohen Y; Tatarsky I
    Cancer; 1987 Sep; 60(5):1060-5. PubMed ID: 3607725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytological and histological classification of multiple myeloma.
    Wutke K; Várbíró M; Rüdiger KD; Kelényi G
    Haematologia (Budap); 1981; 14(3):315-29. PubMed ID: 7327443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of the plasma cell synthesis score in multiple myeloma.
    Pasqualetti P; Collacciani A; Colantonio D; Casale R
    Acta Haematol; 1992; 87(1-2):58-62. PubMed ID: 1585772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prognostic value of the ratio of bone marrow plasma cells in multiple myeloma].
    Pasqualetti P; Colantonio D; Casale R
    Minerva Med; 1990 Mar; 81(3):129-33. PubMed ID: 2320280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow percentage of plasma cells in the staging of monoclonal gammopathies.
    Vercelli D; Di Guglielmo R; Guidi G; Scolari L; Buricchi L; Cozzolino F
    Nouv Rev Fr Hematol (1978); 1980; 22(2):139-45. PubMed ID: 7422542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative study of 2 prognostic classification systems for myeloma and examination of the correlation between initial bone marrow plasmacytosis and prognosis. A propos of a homogeneous population of 50 patients followed from diagnosis to death].
    Pesce A; Cassuto JP; Grisot C; Gratecos N; Bayle J; Viot G; Dujardin P
    Nouv Rev Fr Hematol (1978); 1983; 25(5):311-7. PubMed ID: 6657481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic relevance of a histologic classification system applied in bone marrow biopsies from patients with multiple myeloma: a histopathological evaluation of biopsies from 153 untreated patients.
    Sailer M; Vykoupil KF; Peest D; Coldewey R; Deicher H; Georgii A
    Eur J Haematol; 1995 Mar; 54(3):137-46. PubMed ID: 7720832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined evaluation of bone marrow aspirate and biopsy is superior in the prognosis of multiple myeloma.
    Stifter S; Babarović E; Valković T; Seili-Bekafigo I; Stemberger C; Nacinović A; Lucin K; Jonjić N
    Diagn Pathol; 2010 May; 5():30. PubMed ID: 20482792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Classification and prognostic evaluation in multiple myeloma. A retrospective study of relationship of survivals and responses to chemotherapy to immunological types, 20 single prognostic factors, 15 clinical staging systems, and 6 morphological classifications.
    Pasqualetti P; Colantonio D; Collacciani A; Casale R; Natali G
    Panminerva Med; 1991; 33(2):93-110. PubMed ID: 1923560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognostic value of the degree of morphologic differentiation in multiple myeloma].
    Ludwig H; Fritz E; Radaszkiewicz T
    Verh Dtsch Ges Pathol; 1983; 67():451-8. PubMed ID: 6666274
    [No Abstract]   [Full Text] [Related]  

  • 15. Prognostic value of bone marrow plasma cell infiltration in stage I multiple myeloma.
    Cavo M; Baccarani M; Gobbi M; Lipizer A; Tura S
    Br J Haematol; 1983 Dec; 55(4):683-90. PubMed ID: 6671088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low plasma cell 3(H) thymidine incorporation in monoclonal gammopathy of undetermined significance (MGUS), smouldering myeloma and remission phase myeloma: a reliable indicator of patients not requiring therapy.
    Boccadoro M; Gavarotti P; Fossati G; Pileri A; Marmont F; Neretto G; Gallamini A; Volta C; Tribalto M; Testa MG
    Br J Haematol; 1984 Dec; 58(4):689-96. PubMed ID: 6518137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors in multiple myeloma.
    Cherng NC; Asal NR; Kuebler JP; Lee ET; Solanki D
    Cancer; 1991 Jun; 67(12):3150-6. PubMed ID: 2044058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of bone marrow biopsy and plasma cell morphology in MM and MGUS.
    Bartl R; Frisch B
    Pathol Biol (Paris); 1999 Feb; 47(2):158-68. PubMed ID: 10192882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmablastic morphology is an independent predictor of poor survival after autologous stem-cell transplantation for multiple myeloma.
    Rajkumar SV; Fonseca R; Lacy MQ; Witzig TE; Therneau TM; Kyle RA; Litzow MR; Gertz MA; Greipp PR
    J Clin Oncol; 1999 May; 17(5):1551-7. PubMed ID: 10334543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognostic soundness of the cytologic and histologic examination of the bone marrow in myeloma].
    Bettini R; Rapazzini P; Ferrari V; Ambruzzi AM; Mascalzi MG; Steidl L
    Recenti Prog Med; 1986; 77(7-8):357-61. PubMed ID: 3786936
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.